UK markets open in 4 hours 31 minutes

Cytek Biosciences, Inc. (CTKB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.97-0.05 (-0.83%)
At close: 04:00PM EDT
5.97 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-11,510
-12,148
2,576
3,001
19,411
Depreciation & amortisation
9,889
9,230
5,659
1,242
603
Stock-based compensation
22,989
22,048
16,595
6,586
611
Change in working capital
-12,355
-10,509
-39,928
-8,646
-7,536
Accounts receivable
-9,152
-7,332
-19,744
-12,367
334
Inventory
12,247
4,286
-17,653
-7,068
-5,704
Accounts payable
-1,474
-1,784
1,862
-256
-55
Other working capital
1,436
454
-22,099
266
13,609
Other non-cash items
1,334
1,577
2,178
1,973
323
Net cash provided by operating activities
6,380
5,281
-12,231
4,630
15,156
Cash flows from investing activities
Investments in property, plant and equipment
-4,944
-4,827
-9,868
-4,364
-1,547
Acquisitions, net
-2
-45,132
0
-17,000
0
Purchases of investments
-129,828
-175,935
-46,041
0
0
Sales/maturities of investments
204,000
132,000
0
0
-
Net cash used for investing activities
69,226
-93,894
-55,909
-20,993
-1,547
Cash flows from financing activities
Debt repayment
-558
-565
-50
-2,772
-1,310
Common stock issued
-
0
0
215,689
0
Common stock repurchased
-
-44,151
0
0
-
Other financing activities
-510
-419
-209
-
-
Net cash used provided by (used for) financing activities
-40,199
-41,812
5,513
213,559
122,607
Net change in cash
36,747
-131,870
-65,118
198,499
135,629
Cash at beginning of period
132,394
299,500
364,618
166,119
30,490
Cash at end of period
167,801
167,630
299,500
364,618
166,119
Free cash flow
Operating cash flow
6,380
5,281
-12,231
4,630
15,156
Capital expenditure
-4,944
-4,827
-9,868
-4,364
-1,547
Free cash flow
1,436
454
-22,099
266
13,609